Your trusted destination for CME, CPD & Medical Education across the Middle East.
The International Conference on Oncology and Cancer Biology (ICOCB) is an international research forum that promotes knowledge sharing, professional networking, and international collaboration while providing opportunities for scholarly dissemination through presentations, discussions, and publication-related activities.
The International Conference on Oncology and Cancer Biology (ICOCB) is an international academic conference organized by Research Era. According to the conference organizers, the event is intended to provide an international platform where academicians, researchers, scientists, industry professionals, and students can share their research findings and engage with experts from around the world. The conference seeks to support the dissemination of knowledge, encourage scholarly discussion, and promote the exchange of innovative ideas within the fields of oncology and cancer biology. The organizers state that the key intention of ICOCB is to create opportunities for global participants to share ideas and experiences with peers from different countries. In addition to serving as a venue for research presentations, the conference aims to help delegates establish research and professional relationships, expand their academic networks, and develop international collaborations for future projects and career advancement. Through these interactions, the conference aspires to contribute to the advancement of knowledge in contemporary scientific fields related to oncology and cancer biology. Research Era further highlights several benefits for attendees, including opportunities to interact with international speakers, exchange ideas with fellow researchers, access emerging research developments, and connect with experts from academia and industry. The conference also notes publication and indexing opportunities for selected papers, conference proceedings with ISBN numbers, and the assignment of Digital Object Identifiers (DOIs) through Crossref. According to the organizers, these initiatives are intended to enhance the visibility, accessibility, and academic impact of participants' research contributions.
Exploring the cellular and molecular pathways that drive cancer progression.
Understanding the role of oncogenes and tumor suppressor genes in various cancers.
Advancements in precision medicine and targeted treatments for oncology patients.
Latest developments in harnessing the immune system to fight cancer.
Non-invasive diagnostic techniques for early cancer detection and monitoring.
Identifying biological markers to predict disease outcomes and treatment responses.
All participants will earn CPD Hours, adding professional value and recognition to their academic engagement.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
| Registration | Category | Valid Until | Price |
|---|---|---|---|
| Academician / Practitioner / Industrialists | Early Bird | Aug 28, 2026 | USD 329 |
| Academician / Practitioner / Industrialists | Regular | — | USD 349 |
| Students (All Masters / PhD / Post Doc.) | Early Bird | Aug 28, 2026 | USD 279 |
| Students (All Masters / PhD / Post Doc.) | Regular | — | USD 319 |
| Students (All Bachelors) | Early Bird | Aug 28, 2026 | USD 229 |
| Students (All Bachelors) | Regular | — | USD 249 |
| Attendees / Listener (Without Paper presentation and publication) | Early Bird | Aug 28, 2026 | USD 219 |
| Attendees / Listener (Without Paper presentation and publication) | Regular | — | USD 229 |
| Attendees Online (Presenter) | Early Bird | Aug 28, 2026 | USD 239 |
| Attendees Online (Presenter) | Regular | — | USD 249 |
| Attendees Online (Listner) | Early Bird | Aug 28, 2026 | USD 189 |
| Attendees Online (Listner) | Regular | — | USD 199 |